The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2451486
WO Application Number:
EP2010059599
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP10730170.7
WO Publication Number:
WO2011003886
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
France (FR)
Publications:
Dates
Filing date:
06/07/2010
Grant date:
03/05/2017
EP Publication Date:
16/05/2012
WO Publication Date:
13/01/2011
Claims Translations Received Date:
Claims Translation B1 Received Date:
28/07/2017
Claims Translation B2 Received Date:
12/04/2023
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
03/05/2017
EP B1 Publication Date:
03/05/2017
EP B2 Publication Date:
18/01/2023
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
05/07/2030
Lapsed By Expiration Date:
Patent Validated Date:
14/04/2023
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
11/12/2017
Name:
Jazz Pharmaceuticals II SAS
Address:
84 Quai Charles de Gaulle Cité Internationale, 69006, Lyon, France (FR)
Historical Applicant/holder
From:
03/05/2017
To:
11/12/2017
Name:
Alize Pharma II
Address:
15 Chemin Du Saquin Espace Europeen, 69130 Ecully, France (FR)
European patents granted in amended form for the Netherlands in which an amended translation was filed ex Article 52 par. 6 of the NL Patent Law 1995
2
Bulletin Heading:
EP4
Journal edition number:
03/23
Publication date:
18/01/2023
Description:
European patents granted in amended form for the Netherlands
3
Bulletin Heading:
MED
Journal edition number:
03/23
Publication date:
18/01/2023
Description:
Other communications
4
Bulletin Heading:
VB1
Journal edition number:
12/18
Publication date:
14/03/2018
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention
5
Bulletin Heading:
CO
Journal edition number:
06/18
Publication date:
31/01/2018
Description:
Changes in the Netherlands Patent Register
6
Bulletin Heading:
EP3
Journal edition number:
31/17
Publication date:
02/08/2017
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
7
Bulletin Heading:
EP2
Journal edition number:
18/17
Publication date:
03/05/2017
Description:
European patents granted for the Netherlands
European Patent Bulletin
1
Issue number:
202303
Publication date:
18/01/2023
Description:
Patent maintained (B2 publication)
2
Issue number:
201811
Publication date:
14/03/2018
Description:
Opposition procedure started
3
Issue number:
201718
Publication date:
03/05/2017
Description:
Grant (B1)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC201702451A
Date Registered:
11/12/2017
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
mr. ir. J. van Breda c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
Jazz Pharmaceuticals II SAS
Address:
84 Quai Charles de Gaulle Cité Internationale, 69006, Lyon, France (FR)